#cell-therapy

[ follow ]
Medicine
fromwww.berkeleyside.org
6 days ago

Bayer Berkeley gears up in the fight against Parkinson's disease

Bayer's Berkeley facility is developing bemdaneprocel, an investigational cell therapy for Parkinson's, now entering a pivotal Phase 3 trial with local manufacturing.
Business
fromBoston.com
1 week ago

Major pharmaceutical company announces new round of Greater Boston layoffs

Takeda will cut 137 jobs after discontinuing its cell therapy program while remaining Massachusetts' largest life sciences employer and opening a new R&D facility.
fromNature
2 weeks ago

Swapping old immune cells in the brain with fresh ones could treat disease

A fresh supply of the immune cells that keep the brain tidy might one day help to treat a host of conditions, from ultra-rare genetic disorders to more familiar scourges, such as Alzheimer's disease. In the past few months, a spate of new studies have highlighted the potential of a technique called microglia replacement and explored ways to make it safer and more effective. "This approach is very promising," says Pasqualina Colella, who studies gene and cell therapy at Stanford University School of Medicine in California. "But the caveat is the toxicity of the procedure."
Science
Startup companies
fromSFGATE
3 weeks ago

Bay Area biotech company lays off half its workers a year after raising $325M

Arsenal Biosciences is cutting about half its workforce (≈100 employees) to extend its cash runway while shifting from early-stage research into clinical trials.
#crispr
fromNature
1 month ago
Medicine

Hope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection

fromNature
1 month ago
Medicine

Hope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection

Medicine
fromMedCity News
1 month ago

European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option - MedCity News

European approval permits ExCellThera's UM171 (Zemcelpro) cord‑blood‑derived cell therapy as an allogeneic stem cell transplant option for adults lacking matched donors.
Philosophy
fromMedCity News
2 months ago

The Myth of All-American Drugs and What Trump's Tariffs Miss About Pharma Supply Chains - MedCity News

Nkarta's cell therapies face potential impact from pharmaceutical tariffs affecting supply chain costs and availability of key materials.
US news
fromNature
3 months ago

US-China trade conflict threatens biomedical collaboration

US-China trade conflict hampers biomedical research in China, delaying projects and increasing costs.
Bayern Munich
fromwww.berkeleyside.org
4 months ago

Going green: Bayer's newest Berkeley facility earns LEED platinum

Bayer's new facility in Berkeley received LEED Platinum certification and the Facility of the Year Award for its advancement in sustainable pharmaceutical manufacturing.
Cancer
fromNature
5 months ago

How CAR-T cancer therapies could harm the brain

Cell therapies for cancer can trigger harmful immune responses affecting the brain.
Study results in mice may inform safer cancer treatment strategies in humans.
[ Load more ]